Fibralign Announces Start of European Lymphedema Prevention Clinical Study
Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced enrollment of the first patient in a multi-site, randomized clinical trial...
First Case with CTL Amedica Minimally Invasive Flex Tower
CTL Amedica's detachable Minimally Invasive Flex Tower, currently in beta launch, accompanies the company's Posterior Lumbar MIS Fixation Platforms. The system is designed with a...
HistoSonics Announces First Patient Treated in US Clinical Study of Novel Sonic Beam Therapy for Liver Tumors
Tampa General Hospital is first to treat a patient with liver tumors as part of HistoSonics' #HOPE4LIVER US StudyHistoSonics, developer of a non-invasive platform...
Synergy Disc Enrolls First Patient in Clinical Trial
Synergy Disc Replacement has enrolled the first patient in its U.S. Investigational Device Exemption clinical trial. The multicenter, prospective, historically controlled study will be conducted on...
Study Results for X-Bolt Sliding Hip Screw
Results from the WHITE4 study of X-Bolt Orthopaedics' hip fracture treatment, comparing the X-Bolt® XHS vs. the gold standard Sliding Hip Screw (SHS), indicate...
Ancora Heart Enrolls 1st Patient in CORCINCH-HF Trial
Ancora Heart has enrolled the first patient in the CORCINCH-HF pivotal trial. The study is designed to evaluate the safety and efficacy of the...
Surmodics drug-coated balloon on par with Medtronic’s in study
Surmodics' drug-coated balloon to treat peripheral artery disease was found to be non-inferior to Medtronic's market-leading IN.PACT Admiral device, meeting primary endpoints for safety...
Sky Medical Technology and Barnsley Hospital NHS Foundation Trust shortlisted for Bionow award for obstetrics blood clot prevention study
Sky Medical Technology (Sky) has been shortlisted for the Healthcare Project of the Year at the Bionow awards, for its work with Barnsley Hospital...
Turn Therapeutics Receives Authorization to Commence Human Trial for COVID-19 Therapeutic Candidate
Intranasal antiviral may fill key gaps in treatment and preventionTurn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, announced the...